Precision Medicine leaps forward A randomised control trial published in the Journal of Alzheimers Disease (JAD) this year, 2022, in the UK looked at people with early stage dementia. Twenty-five patients with dementia or mild cognitive impairment were evaluated for a number of underlying issues including things such as inflammation, infection or vascular disease. Each…